tiprankstipranks
Hepion Pharmaceuticals (HEPA)
OTHER OTC:HEPA
US Market
HEPA
Hepion Pharmaceuticals
RESEARCH TOOLSreports

Hepion Pharmaceuticals (HEPA) Income Statement

793 Followers

Hepion Pharmaceuticals Income Statement

Last quarter (Q4 2025), Hepion Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Hepion Pharmaceuticals's net income was $-656.88K. See Hepion Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Operating Expenses
$ 4.16M$ 19.35M$ 48.45M$ 45.49M$ 30.40M
Depreciation and Amortization
$ 0.00$ 30.76K$ 67.13K$ 77.46K$ 86.07K
EBITDA
$ -8.25M$ -14.88M$ -49.26M$ -45.00M$ -32.63M
Operating Income
$ -4.16M$ -19.35M$ -48.45M$ -45.49M$ -30.40M
Other Income/Expenses
$ -4.11M$ 3.18M$ -887.11K$ 404.83K$ -2.32M
Pretax Income
$ -8.28M$ -16.16M$ -49.34M$ -45.08M$ -32.72M
Net Income
$ -8.28M$ -13.19M$ -48.93M$ -42.20M$ -32.72M
Per Share Metrics
Basic EPS
$ -0.88$ -107.35$ -616.07$ -594.75$ -465.52
Diluted EPS
$ -0.88$ -107.35$ -616.07$ -594.75$ -465.52
Weighted Average Shares Outstanding
 9.41M 122.89K 79.42K 76.23K 70.29K
Weighted Average Shares Outstanding (Diluted)
 9.41M 122.89K 79.42K 76.23K 70.29K
Currency in USD

Hepion Pharmaceuticals Earnings and Revenue History